Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

294

HTML

2476

Figures (1-3)

251

Tables (1-1)

232

Sum=3253

May 26, 2010 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Cardiol. May 26, 2010; 2(5): 125-130
Published online May 26, 2010. doi: 10.4330/wjc.v2.i5.125

Full Size Figure Download Figure

Figure 2 Significant reduction of left ventricular mass (A) and relative wall thickness (B) after 3 mo of treatment (T1) vs baseline (T0).

Citation: Ruvolo A, Mercurio V, Fazio V, Carlomagno G, Russo T, Affuso F, Fazio S. Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure. World J Cardiol 2010; 2(5): 125-130
URL: https://www.wjgnet.com/1949-8462/full/v2/i5/125.htm
DOI: https://dx.doi.org/10.4330/wjc.v2.i5.125